IRADIMED CORP (IRMD) Stock Balance Sheet
NASDAQ:IRMD - Nasdaq - US46266A1097 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 50.33M | 52.23M | 49.76M | 57.96M | 62.00M | |||
| Marketable Securities | N/A | N/A | N/A | 0.00 | 500.00K | |||
| Receivables | 12.71M | 10.56M | 12.22M | 13.53M | 8.44M | |||
| Inventories | 10.56M | 10.40M | 12.82M | 5.37M | 4.30M | |||
| Other Current Assets | 1.54M | 24.52M | 1.19M | 630.00K | 1.00M | |||
| Total Current Assets | 75.14M | 75.24M | 76.00M | 77.49M | 76.24M | |||
| Non-Current Assets | ||||||||
| PPE Net | 20.44M | 16.97M | 11.33M | 4.61M | 4.55M | |||
| Intangibles | 3.26M | 3.10M | 2.52M | 2.07M | 1.12M | |||
| Other Non-Current Assets | 2.90M | 3.02M | 2.30M | 1.35M | 970.00K | |||
| Total Non-Current Assets | 26.59M | 23.08M | 16.16M | 8.02M | 6.64M | |||
| TOTAL ASSETS | 101.73M | 98.33M | 92.16M | 85.51M | 82.88M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 2.58M | 4.09M | 3.31M | 3.29M | 3.23M | |||
| Accounts Payable | 2.59M | 1.90M | 1.86M | 1.80M | 780.00K | |||
| Other Current Liabilities | 3.30M | 2.53M | 11.16M | 3.47M | 2.81M | |||
| Total Current Liabilities | 8.47M | 8.51M | 16.33M | 8.55M | 6.82M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 3.20M | 2.99M | 4.41M | 3.29M | 3.88M | |||
| Total Non-Current Liabilities | 3.20M | 2.99M | 4.41M | 3.29M | 3.89M | |||
| TOTAL LIABILITIES | 11.68M | 11.51M | 20.74M | 11.84M | 10.71M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 59.32M | 56.79M | 43.26M | 47.26M | 46.99M | |||
| Additional Paid In Capital | 30.74M | 30.03M | 28.16M | 26.41M | 25.16M | |||
| Common Shares | 1.30K | 1.30K | 1.30K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | 86.82M | N/A | 0.00 | 20.00K | |||
| Shares Outstanding | 12.72M | 12.71M | 12.66M | 12.59M | 12.54M | |||
| Tangible Book Value per Share | 6.83 | 6.59 | 5.44 | 5.69 | 5.67 | |||
| Total Shareholders' Equity | 90.05M | 86.82M | 71.42M | 73.67M | 72.17M | |||
| TOTAL LIABILITIES AND EQUITY | 101.73M | 98.33M | 92.16M | 85.51M | 82.88M | |||
| Statistics | ||||||||
| Current Ratio | 8.87 | 8.84 | 4.65 | 9.06 | 11.18 | |||
| Return On Assets (ROA) | 19.45% | 19.56% | 18.66% | 15.00% | 11.26% | |||
| Return On Equity (ROE) | 21.97% | 22.15% | 24.07% | 17.42% | 12.93% | |||
| Return On Invested Capital (ROIC) | 19.22% | 19.36% | 20.92% | 16.08% | 10.22% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 41.77% | 46.27% | 60.85% | 65.12% | 57.33% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 45.20% | 50.43% | 67.35% | 73.08% | 62.49% | |||
All data in USD , ROIC based on taxRate of 0.21